5-Fluorouracil-induced severe but reversible cardiogenic shock: A case report

Tumori

Volumn 82, Issue 5, 1996, Pages 505-507

  Akhtar, Shad S ^a,b   Wani, Bashir A ^a   Bano, Zareefa A ^a   Salim, Khalida P ^a   Handoo, Fayaz A ^a  

^a SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

^b King Fahd Specialist Hospital Buraidah   (Saudi Arabia)

Author keywords

5 fluorouracil; cardiotoxicity; myocardial dysfunction

Indexed keywords

CISPLATIN; DOPAMINE; FLUOROURACIL; ISOPRENALINE;

ADULT; ARTICLE; CARDIOGENIC SHOCK; CARDIOTOXICITY; CASE REPORT; ELECTROCARDIOGRAM; ESOPHAGUS CARCINOMA; HUMAN; MALE; SWEATING; TACHYCARDIA;

EID: 0030481654     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169608200522     Document Type: Article

References (27)

1. Akhtar S.S., Salim K., Bano Z.A.: Symptomatic cardiotoxicity with high-dose 5-fluorouracil infusion: a prospective study. Oncology, 50: 441-444, 1993.
2. Chaudary S., Thomas Song S.Y., Jaski B.E.: Profound yet reversible heart failure secondary to 5-fluorouracil. Am. J. Med., 85: 454-456, 1988.
3. Dent R.G., McColl I.: 5-fluorouracil and angina (Letter). Lancet, 1: 347-348, 1975.
4. Doll D.C., List A.F., Greco A., Hainsworth J.D., Hande K.R., Johnson D.H.: Acute vascular ischaemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis. Ann. Intern. Med., 105: 48-51, 1986.
5. Freeman N., Costanza M.: 5-fluorouracil-associated cardiotoxicity. Cancer, 61: 36-45, 1988.
6. Gamelin E., Gamelin L., Larra F., Turcant A., Alain P., Maillart P., Allain Y.M., Minier J.f., Dubin J.: Acute toxicity of 5-fluorouracil: pharmacokinetic correlation. Bull. Cancer Paris, 78: 1147-1153, 1991.
7. Gradishar W.J., Yokes E.E.: 5-fluorouracil cardiotoxicity: a critical review. Ann. Oncol., 1: 409-414, 1990.
8. Hansen S.W., Olsen N., Rossing N., Rorth M.: Vascular toxicity and the mechanism underlying Raynaud's phenomenon in patients treated with cisplatin, vinblastine and bleomycin. Ann. Oncol., 1: 289-292, 1990.
9. Haskel C.M.: Drugs used in cancer chemotherapy. In: Cancer treatment, Haskel C.M., Ed., 2nd edn., pp. 43-106, W.B. Saunders, Philadelphia, 1984.
10. Jakubowski A.A., Kemeny N.: Hypotension as a manifestation of cardiotoxicity in three patients receiving cisplatin and 5-fluorouracil. Cancer, 62: 266-269, 1988.
11. Kuzel T., Esparaz B., Green D., Kies M.: Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cis-platin. Cancer, 65: 885-889, 1990.
12. Labianca R., Beretta G., Clerici M., Fraschini P., Luporini G.I.: Cardiotoxicity of 5-fluorouracil: a study of 1,083 patients. Tumori, 68: 505-510, 1982.
13. Labianca R., Luporini G.: 5-fluorouracil cardiotoxicity: the risk of rechallenge. Ann. Oncol., 2: 383, 1991.
14. Leone B., Rabinovich M., Ferrari C.R., Boyer J., Rosso H., Strauss E.: Cardiotoxicity as a result of 5-fluorouracil therapy. Tumori, 71: 55-57, 1985.
15. Levillain R., Ramona F., Cluzan R.: Utilité eventuelle des examens cardiaques répétés chez les cancereaux subissant une chimiothérapie intensive et prolongée. Therapie, 29: 101-108, 1974.
16. Liss R.H., Chadwick M.: Correlation of 5-fluorouracil distribution in rodents with toxicity and chemotherapy in man. Cancer Chemother. Rep., 58: 777-786, 1974.
17. Matsubara I., Kamiya J., Imai S.: Cardiotoxic effects of 5-fluorouracil in the guinea pig. Jpn. J. Pharmacol., 30: 871-879, 1980.
18. McKendall G.R., Shurman A., Anamur M., Most A.S.: Toxic cardiogenic shock associated with infusion of 5-fluorouracil. Am. Heart J., 118: 184-186, 1989.
19. Pottage A., Holt S., Ludgate S., Langlands A.: Fluorouracil cardiotoxicity. Br. Med. J., 1: 547, 1978.
20. Rezkalla S., Kloner R.A., Ensley J., al-Sarraf M., Revels S., Olivestein Á., Bhasin S., Kerpel-Fronious S., Turi Z.G.: Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study. J. Clin. Oncol., 7: 509-514, 1989.
21. Riela A., Kimball J.B., Paterson R.B.: 5-FU cardiotoxicity.
22. Roth A., Kalaric K., Popovic S.: Cardiotoxicity of 5-fluorouracil. Cancer Chemother. Rep., 59: 1051-1052, 1975.
23. Sanani S., Spaulding M.B., Masud A.R., Canty R.: 5-FU cardiotoxicity. Cancer Treat. Rep., 65: 1123-1125, 1981.
24. Soukop M., McVie J.G., Calman K.C.: Fluorouracil cardiotoxicity. Br. Med. J., 1: 1422, 1978.
25. Stevenson D.L., Mikhailidis O.P., Gillett D.S.: Cardiotoxicity of 5-fluorouracil. Lancet, 2: 406-407, 1977.
26. Tomirotti M., Riundi R., Pulici S., Ungaro A., Peoretti D., Villa S., Scanni A.: Ischemic cardtopathy from cis-diammine-dichloroplatinum (CDDP). Tumori, 70: 235-236, 1984.
27. Yorobiof D.A.: Cardiotoxicity of 5-fluorouracil. Case report. South African Med. J., 61: 634-635, 1982.